Thursday November 26 2009 | Biotechnology feed | All feeds

Spectral announces publication demonstrating Toraymyxin(TM) significantly reduces mortality from sepsis in prospective controlled trial

Thursday 18th of June 2009 7:00

BioPortfolio no longer holds the full text of this article, it is however likley to be available via the below links:

Browse other news from this organisation: Spectral Diagnostics Inc.

(If any, Generated Automatically)

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.